CONFERENCE DAY ONE
WEDNESDAY, JULY 17 2019

8.45

Chair’s Opening Remarks

9.00

‘IMPACCT’ Panel Discussion: Implementing Patient-Centric Clinical Transformation – A Guide on What We Know & What We Still Look to Achieve

• Analyzing the changing clinical research paradigm and the role of digitallyenabled approaches in clinical innovation – enhancing research outcomes and patient-facing medicine
• Old vs. New – balancing optimization of processes and approaches with digital tools vs.
complete disruption of the clinical R&D model (e.g. virtual trials)
• Are we transforming the traditional model of clinical research, or just disrupting it with technology?
• Discussing technology implementation in clinical research – is it happening because it’s
available or are we solving any specific problems?
• Ensuring the value and ROI of digital innovation in clinical trials – would we continue in our
journey for patient-centric, technology-enabled trials without reductions in cost or time?
• How can digital and clinical innovation teams be effectively organized and structured? And how can we integrate them in to the process?
• Defining a holistic view on how to implement technology into clinical research: key challenges and what’s next

Craig Lipset
Pfizer

Georgia Mitsi
Sunovion Pharmaceuticals

Jeremy Wyatt
ActiGraph

Kyle Holen
AbbVie

Rethinking Clinical Trial Methodology

9.45

From the Current State to the Future – What Digital Gaps Remain?

• Reviewing the current state of digital in medicine development against a desired future
• Identifying the gaps that remain to create the future of digital in clinical development
• Exploring what it will take to create the future

Craig Lipset
Head of Clinical Innovation
Pfizer

 

10.15

Speed Networking Session

10.45

Morning Refreshments

11.15

The End of Manual Data Entry in Clinical Research

• Why is our current system of data capture failing us?
• How is AbbVie tackling this problem? – reviewing case-studies
• Discussing the future of data capture in clinical research

Kyle Holen
Head of Development, Design Center
AbbVie

11.45

Reimagining the Current Standard Clinical Trial Approach – The Patient
Centric Remote Trial Model

• Analyzing the patient centric remote trial model and the huge potential it offers to reimagine the current standard clinical trial approach
• Discussing the possibilities and pathways to approach this promising new paradigm
• Sharing Novartis experience on bringing trials to patients, the challenges and learnings in implementation, and considerations for scalability

Ching Tian
General Manager, Digital Accelerator
Novartis

 

12.15

Digitization of Dermatology – Is It Happening?

• Overviewing the use of digital patient tools in dermatology
• Digitization of clinical trials in dermatology – addressing real-world data generated in clinical trials from digital tools
• Providing insight into LEO Innovation Lab’s first virtual clinical trial

Rasmus Hogreffe
Head of Virtual Clinical Trials
LEO Innovation Lab

 

12.45

Lunch & Networking

1.45

Using Passive Monitoring & AI to Characterize the Home Lives of those with Parkinson Disease

• Describing a novel remote sensing technology, Emerald, and how artificial intelligence can enhance its capabilities
• Demonstrating real world feasibility of Emerald to analyze and interpreting the clinical meaning of its output
• Presenting initial results of a Parkinson Disease Study with a particular focus on gait, home activity, and time in bed

Zachary Kabelac
Senior Researcher
MIT

 

Digitization in Clinical Studies – Behind the Scenes

2.15

Lessons Learned from Implementing Technologies in Large Scale Trials

• Deciding on the right technology and the right trial
• Ensuring seamless coordination among external stakeholders
• Defining success

Georgia Mitsi
Senior Director – Search Evaluation, Digital Healthcare
Sunovion Pharmaceuticals

 

2.45

Conducting a Successful Digital Clinical Trial – Key Considerations from The Field

• Discussing what are the key stakeholders to involve when setting up your digital trial
• Addressing data security & privacy from a patient and hospital perspective
• Setting yourself up for success by matching your digital solution to the right trial setting and participant group

Amanda Centi
Research Program Manager
Partners Healthcare

 

3.15

Afternoon Refreshments & Networking

3.45

Mobile Measures in Parkinson's Disease & Huntington's Disease

• Discussing the rationale for incorporating mobile measures into clinical trials
• Reviewing Parkinson’s disease and Huntington’s disease wearable sensor and smartphone application studies conducted at the University of Rochester
• Considering future directions

Jamie Adams
Assistant Professor, Department of Neurology & Center for Health + Technology
University of Rochester Medical Center

4.15

AI, Blockchain & Wearables in Clinical Trials: A Dose of Reality

• Analyzing the massive uptick in pharma industry’s interest in technology, especially in artificial intelligence (AI), blockchain and wearables and how these can be leveraged to lower the time to market for specific drugs
• Addressing some use cases – real-world viability and blockers preventing them from becoming a reality
• Discussing new developments in the space that have the potential to significantly impact incumbent practices in clinical research
• Focusing on the right questions to ask

Ameya Phadke
Senior Manager, Technology & Digital Partnerships
Chiesi USA

 

4.45

Chair’s Closing Remarks